EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor

Wenpeng Cai, Tao Fan, Chu Xiao iD, Ziqin Deng, Yixiao Liu, Chunxiang Li, Jie He iD

Cancer Communications · 2025-08 · 45 (8) · 888-913

DOI: 10.1002/cac2.70027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 29.04.2025. Verfasst von Wenpeng Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Neutrophils, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 307 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, R&D Program of Beijing Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their short half‐life, especially as there is limited information on the role of intratumoral neutrophils. Recent studies on their prominent role in cancer have led to a paradigm shift in our understanding of the functional diversity of neutrophils. These studies highlight that neutrophils have emerged as key components of the tumor microenvironment, where they can play a dual role in promoting and suppressing cancer. Moreover, several approaches to therapeutically target neutrophils have emerged, and clinical trials are investigating their efficacy. In this review, we discussed the involvement of neutrophils in cancer initiation and progression. We summarized recent advances in therapeutic strategies targeting neutrophils and, most importantly, suggested future research directions that could facilitate the manipulation of neutrophils for therapeutic purposes in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsNeoplasmsTumor MicroenvironmentHumansAnimals

Stichwörter der Autor:innen

cancer therapyimmunologytumor microenvironmenttumor‐associated neutrophil

Autor:innen und Institutionen

  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.

ORCID-Profile: Chu Xiao, Jie He

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • R&D Program of Beijing Municipal Education Commission
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Cai, W., Fan, T., Xiao, C., Deng, Z., Liu, Y., Li, C., & He, J. (2025). Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor. Cancer Communications, 45(8), 888-913. https://doi.org/10.1002/cac2.70027

Vancouver

Cai W, Fan T, Xiao C, Deng Z, Liu Y, Li C, et al. Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor. Cancer Communications. 2025;45(8):888-913. doi:10.1002/cac2.70027

BibTeX
@article{Cai2025,
  author = {Cai, Wenpeng and Fan, Tao and Xiao, Chu and Deng, Ziqin and Liu, Yixiao and Li, Chunxiang and He, Jie},
  title = {Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor},
  journal = {Cancer Communications},
  year = {2025},
  volume = {45},
  number = {8},
  pages = {888--913},
  doi = {10.1002/cac2.70027}
}
Kostenlos starten →